Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (4) Begay-Müller, Valerie Dr. (1) Berruezo Llacuna, Maria (1) Beule, Dieter Dr. (1) Costanza, Mariantonia Dr. (5) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (4) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Farre i Diaz, Carlota (1) Franke, Vedran Dr. (3) Gerlach, Kerstin (1) Graf, Robin Dr. (2) Heuser, Arnd Dr. (1) Hinz, Michael Dr. (4) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (2) Hübner, Norbert Prof. Dr. (2) Janz, Martin Dr. (58) Keller, Lisa (1) Kocks, Christine Dr. (1) Kolesnichenko, Marina Dr. (1) Langner, Patrick (1) Leutz, Achim Prof. Dr. (3) Lusatis, Simone (2) Mertins, Philipp Dr. (2) Na, Il-Kang Dr. (1) Napieczynska, Hanna Dr. (1) Patone, Giannino Dr. (2) Pezzutto, Antonio Prof. Dr. (1) Popp, Oliver Dr. (1) Prigione, Alessandro Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (7) Rehm, Armin Dr. (2) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (13) Schmitt, Clemens Prof. Dr. (3) Sczakiel, Henrike (3) Selbach, Matthias Prof. Dr. (1) Specker, Edgar Dr. (1) Stein, Ulrike Prof. Dr. (1) von Kries, Jens Peter Dr. (1) Walther, Wolfgang Prof. Dr. (1) Wollert-Wulf, Brigitte (7) (-) Mathas, Stephan Dr. (71) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (1) 2004 (2) 2005 (2) 2006 (4) 2007 (3) 2008 (4) 2009 (3) 2010 (3) 2011 (4) 2012 (1) 2013 (1) 2014 (2) 2015 (5) 2016 (2) 2017 (3) 2018 (1) 2019 (2) 2020 (3) 2021 (3) 2022 (4) 2023 (7) 2024 (4) AG Müller/Dechend (ECRC) (6) Animal Phenotyping (1) Bioinformatics and Omics Data Science (5) (-) Biology of Malignant Lymphomas (72) Cancer Genetics and Cellular Stress Responses (3) Chemical Biology (3) Computational Regulatory Genomics (1) From Cell States to Function (1) Genetics and Genomics of Cardiovascular Diseases (15) Genome Diversification & Integrity (3) Genomics (1) Hypertension-caused End-Organ Damage (6) Hypertension-Mediated End-Organ Damage (6) Immune Regulation and Cancer (3) Integrative Vascular Biology (1) Mechanism-based Cancer Therapies (4) Microenvironmental Regulation in Autoimmunity and Cancer (1) Molecular Biology of Peptide Hormones (1) Molecular Genetics of Chronic Inflammation and Allergic Disease (1) Pluripotent Stem Cells (1) Proteome Dynamics (2) Proteomics (2) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (1) RNA Biology and Posttranscriptional Regulation (2) Screening Unit (3) Structural Biology of Membrane-Associated Processes (5) Systems Biology Imaging (1) Systems Biology of Gene Regulatory Elements (7) Translational Bioinformatics (1) 72 Results: Active Filter: Mathas, Stephan Dr.Biology of Malignant Lymphomas Sort: Result score Newest to oldest Oldest to newest May 29, 2024 / Mol Cancer JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression T. Redmer M. Raigel C. Sternberg R. Ziegler C. Probst D. Lindner A. Aufinger T. Limberger K. Trachtova P. Kodajova S. Högler M. Schlederer S. Stoiber M. Oberhuber M. Bolis H.A. Neubauer S. Miranda M. Tomberger N.S. Harbusch I. Garces de Los Fayos Alonso F. Sternberg R. Moriggl J.P. Theurillat B. Tichy V. Bystry J.L. Persson S. Mathas F. Aberger B. Strobl S. Pospisilova O. Merkel G. Egger S. Lagger L. Kenner August 01, 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit March, 2024 / Lancet Haematol High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial E. Schorb L.K. Isbell A. Kerkhoff S. Mathas F. Braulke G. Egerer A. Röth S. Schliffke P. Borchmann U. Brunnberg F. Kroschinsky R. Möhle A. Rank D. Wellnitz B. Kasenda L. Pospiech J. Wendler F. Scherer M. Deckert E. Henkes P. von Gottberg D. Gmehlin M. Backenstraß A. Jensch E. Burger-Martin O. Grishina H. Fricker N. Malenica A. Orbán J. Duyster G. Ihorst J. Finke G. Illerhaus July 27, 2024 / Lancet Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial P. Borchmann J. Ferdinandus G. Schneider A. Moccia R. Greil M. Hertzberg V. Schaub A. Hüttmann F. Keil J. Dierlamm M. Hänel U. Novak J. Meissner A. Zimmermann S. Mathas J.M. Zijlstra A. Fosså A. Viardot B. Hertenstein S. Martin P. Giri S. Scholl M.S. Topp W. Jung V. Vucinic H.J. Beck A. Kerkhoff B. Unger A. Rank R. Schroers C.M. zum Büschenfelde M. de Wit K. Trautmann-Grill P. Kamper D. Molin S. Kreissl H. Kaul B. von Tresckow S. Borchmann K. Behringer M. Fuchs A. Rosenwald W. Klapper H.T. Eich C. Baues A. Zomas M. Hallek M. Dietlein C. Kobe V. Diehl March, 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto May, 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas October, 2007 / Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas January 01, 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken April 19, 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next › Last page Last »
May 29, 2024 / Mol Cancer JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression T. Redmer M. Raigel C. Sternberg R. Ziegler C. Probst D. Lindner A. Aufinger T. Limberger K. Trachtova P. Kodajova S. Högler M. Schlederer S. Stoiber M. Oberhuber M. Bolis H.A. Neubauer S. Miranda M. Tomberger N.S. Harbusch I. Garces de Los Fayos Alonso F. Sternberg R. Moriggl J.P. Theurillat B. Tichy V. Bystry J.L. Persson S. Mathas F. Aberger B. Strobl S. Pospisilova O. Merkel G. Egger S. Lagger L. Kenner
August 01, 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit
March, 2024 / Lancet Haematol High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial E. Schorb L.K. Isbell A. Kerkhoff S. Mathas F. Braulke G. Egerer A. Röth S. Schliffke P. Borchmann U. Brunnberg F. Kroschinsky R. Möhle A. Rank D. Wellnitz B. Kasenda L. Pospiech J. Wendler F. Scherer M. Deckert E. Henkes P. von Gottberg D. Gmehlin M. Backenstraß A. Jensch E. Burger-Martin O. Grishina H. Fricker N. Malenica A. Orbán J. Duyster G. Ihorst J. Finke G. Illerhaus
July 27, 2024 / Lancet Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial P. Borchmann J. Ferdinandus G. Schneider A. Moccia R. Greil M. Hertzberg V. Schaub A. Hüttmann F. Keil J. Dierlamm M. Hänel U. Novak J. Meissner A. Zimmermann S. Mathas J.M. Zijlstra A. Fosså A. Viardot B. Hertenstein S. Martin P. Giri S. Scholl M.S. Topp W. Jung V. Vucinic H.J. Beck A. Kerkhoff B. Unger A. Rank R. Schroers C.M. zum Büschenfelde M. de Wit K. Trautmann-Grill P. Kamper D. Molin S. Kreissl H. Kaul B. von Tresckow S. Borchmann K. Behringer M. Fuchs A. Rosenwald W. Klapper H.T. Eich C. Baues A. Zomas M. Hallek M. Dietlein C. Kobe V. Diehl
March, 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto
May, 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
October, 2007 / Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas
January 01, 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken
August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
April 19, 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken